Due to their controllable size, low cytotoxicity, and unique architecture, cyclodextrin‐based polyrotaxanes and pseudopolyrotaxanes have been developed to encompass a broad range of diverse medical applications from erodable hydrogels to drug and gene delivery. This review summarizes the synthesis, characterization, dynamics, applications, and potential utility of cyclodextrin based polyrotaxanes and pseudopolyrotaxanes for medical applications. Specifically, this article reviews the literature appearing on this topic between 1999 and November 2006.
No takes yet. Share an insight, caveat, or question.
Loethen et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: